Literature DB >> 8031321

Interstrand DNA crosslinking induced by anthracyclines in tumour cells.

A Skladanowski1, J Konopa.   

Abstract

Using a new mild method it is shown for two anthracyclines, Adriamycin and Daunomycin, that these compounds are able to form DNA crosslinks in HeLa S3 cells. It was also found that other anthracyclines: Epirubicin, Rubidazone, Iodorubicin, 3'-deamino-3'-hydroxy-4'-amino-Adriamycin, Aclacinomycin, Marcellomycin, and Cinerubin A, induced crosslinks in the DNA of HeLa S3 cells in a concentration-dependent manner. DNA crosslinks formed by five anthracyclines studied, excluding Iodorubicin, were both alkali and thermally unstable. No DNA crosslinking could be detected when the compounds were added to cell lysates in which cellular enzymes had been inactivated. This implies that metabolic activation is prerequisite for DNA crosslinking by anthracyclines. The kinetics of DNA crosslinks formation by Adriamycin as well as their removal from cellular DNA were also studied. The presented results indicate that all biologically active anthracyclines studied induce DNA crosslinks, and for two of them DNA crosslinking was observed at growth inhibitory concentrations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031321     DOI: 10.1016/0006-2952(94)90265-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  14 in total

1.  Interstrand cross-linking by adriamycin in nuclear and mitochondrial DNA of MCF-7 cells.

Authors:  C Cullinane; S M Cutts; C Panousis; D R Phillips
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

2.  Stability of adriamycin-induced DNA adducts and interstrand crosslinks.

Authors:  A van Rosmalen; C Cullinane; S M Cutts; D R Phillips
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

3.  Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients.

Authors:  E Castro; D Olmos; A Garcia; J J Cruz; R González-Sarmiento
Journal:  Clin Transl Oncol       Date:  2013-06-06       Impact factor: 3.405

4.  Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice.

Authors:  Katerina Naka K; Patra Vezyraki; Alexandros Kalaitzakis; Stelios Zerikiotis; Lampros Michalis; Charalampos Angelidis
Journal:  Cell Stress Chaperones       Date:  2014-04-20       Impact factor: 3.667

5.  Mechanisms of Doxorubicin Toxicity in Pancreatic β-Cells.

Authors:  Emma A Heart; Shpetim Karandrea; Xiaomei Liang; Maren E Balke; Patrick A Beringer; Elyse M Bobczynski; Delaine Zayas-Bazán Burgos; Tiffany Richardson; Joshua P Gray
Journal:  Toxicol Sci       Date:  2016-06-02       Impact factor: 4.849

6.  Doxazolidine induction of apoptosis by a topoisomerase II independent mechanism.

Authors:  Brian T Kalet; Meagan B McBryde; Joaquin M Espinosa; Tad H Koch
Journal:  J Med Chem       Date:  2007-08-16       Impact factor: 7.446

7.  Characterization of covalent adriamycin-DNA adducts.

Authors:  S M Zeman; D R Phillips; D M Crothers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

8.  Use of oligonucleotides to define the site of interstrand cross-links induced by Adriamycin.

Authors:  S M Cutts; D R Phillips
Journal:  Nucleic Acids Res       Date:  1995-07-11       Impact factor: 16.971

9.  IS METABOLIC ACTIVATION OF TOPOISOMERASE II POISONS IMPORTANT IN THE MECHANISM OF CYTOTOXICITY?

Authors:  Birandra K Sinha; Ronald P Mason
Journal:  J Drug Metab Toxicol       Date:  2015-07-24

10.  A cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets Wolbachia.

Authors:  Laura R Serbus; Frederic Landmann; Walter M Bray; Pamela M White; Jordan Ruybal; R Scott Lokey; Alain Debec; William Sullivan
Journal:  PLoS Pathog       Date:  2012-09-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.